New Key Statistics Module, Z-Score and F-Score
OTCPK:PCLOF Key Ratios
| Market Cap $ M | 8.61 |
| Enterprise Value $ M | 21.62 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 4.29 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 1.00 |
| EPS (TTM) $ | -0.01 |
| Beneish M-Score | -2.91 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 59.50 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -25.48 |
| EV-to-EBITDA | -68.36 |
| PEG | -- |
| Shares Outstanding M | 200.14 |
| Net Margin (%) | -141.03 |
| Operating Margin % | -131.65 |
| Pre-tax Margin (%) | -141.03 |
| Quick Ratio | 0.07 |
| Current Ratio | 0.15 |
| ROA % (ttm) | -29.90 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -12.14 |
| Dividend Yield % | -- |
| Altman Z-Score | -25.51 |
PCLOF Number of Guru Trades
PCLOF Volume of Guru Trades
Gurus Latest Trades with OTCPK:PCLOF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:PCLOF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
PharmaCielo Ltd Insider Transactions
No Available Data
News about OTCPK:PCLOF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers